Sensei Biotherapeutics In... (SNSE)
NASDAQ: SNSE
· Real-Time Price · USD
8.68
1.18 (15.73%)
At close: Aug 15, 2025, 3:59 PM
8.80
1.38%
After-hours: Aug 15, 2025, 07:56 PM EDT
Sensei Biotherapeutics Fail-to-Deliver
Total FTD Shares
828
Below Average
FTD / Avg. Volume
4.93%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jul 11, 2025,
Sensei Biotherapeutics Inc. has
828
shares failed to deliver, representing 4.93%
of the average daily volume of
16,804
shares. Over the past year, the monthly average FTD is
12,858
shares, with the current level 94% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jul 11, 2025 | 8.17 | 828 | +471.03% |
| Jun 30, 2025 | 8.58 | 145 | -95.17% |
| May 20, 2025 | 6.21 | 3K | +257.14% |
| Apr 30, 2025 | 8.06 | 840 | -99.69% |
| Mar 31, 2025 | 7.88 | 270.52K | +33011.14% |
| Feb 27, 2025 | 8.78 | 817 | -93.08% |
| Jan 31, 2025 | 9.4 | 11.81K | -52.64% |
| Dec 31, 2024 | 9.8 | 24.93K | +531.62% |
| Nov 26, 2024 | 10.69 | 3.95K | +651.81% |
| Oct 24, 2024 | 11.8 | 525 | -79.00% |
| Sep 30, 2024 | 11.96 | 2.5K | +1793.94% |
| Aug 28, 2024 | 12.04 | 132 | -80.95% |
| Jul 31, 2024 | 13.2 | 693 | +6.13% |
| Jun 27, 2024 | 13.3 | 653 | -87.61% |
| May 31, 2024 | 14.79 | 5.27K | +84.27% |
| Apr 26, 2024 | 20.4 | 2.86K | +460.78% |
| Mar 27, 2024 | 21.8 | 510 | -47.26% |
| Feb 29, 2024 | 17 | 967 | -83.19% |
| Jan 31, 2024 | 16.4 | 5.75K | +37.62% |
| Dec 29, 2023 | 13.84 | 4.18K | +661.20% |
| Nov 30, 2023 | 14.4 | 549 | +89.31% |
| Oct 19, 2023 | 13.7 | 290 | -17.61% |
| Sep 20, 2023 | 17.2 | 352 | +40.24% |
| Aug 14, 2023 | 23 | 251 | +457.78% |
| Jul 26, 2023 | 25.6 | 45 | -96.57% |
| Jun 29, 2023 | 26.8 | 1.31K | -90.90% |
| Apr 24, 2023 | 31.6 | 14.43K | +465.88% |
| Mar 23, 2023 | 27.6 | 2.55K | +7627.27% |
| Feb 06, 2023 | 29.9 | 33 | -98.93% |
| Jan 27, 2023 | 30.2 | 3.08K | n/a |